"I am glad that taking part in a trial might help others on their own cancer journey.”
A trial looking at surgery for mesothelioma (MARS 2)
This trial is comparing surgery with no surgery for people who have mesothelioma of the chest. Mesothelioma is a type of cancer that can develop in the covering of the lungs (pleural mesothelioma). It is recruiting people who have pleural mesothelioma that is only affecting one side of the chest. The trial is supported by Cancer Research UK.
More about this trial
Doctors can treat mesothelioma in the chest with chemotherapy, radiotherapy and surgery. Some surgeons think that it may be useful for people to have an operation called a pleurectomy decortication as well as chemotherapy. This surgery involves the removal of:
- any visible mesothelioma
- the hardened and thickened outer layer of the surface of the lung (decortication)
- the lung covering (pleura)
Depending on where the cancer is in the covering of the lungs, some patients will also require the removal of:
- part or all of the lining of the heart (the pericardium)
- the sheet of muscle just under the rib cage (the diaphragm)
This operation is called an extended pleurectomy decortication.
In both operations the lung is not removed. This is called lung sparing surgery. Sparing the lung in this operation may mean people have fewer problems after surgery, for example with shortness of breath.
At the moment there is little research looking at whether surgery helps people and whether chemotherapy and surgery is better than chemotherapy alone. Researchers hope that a combination of both treatments will help people to live longer as well as improve their quality of life.
In this trial, everyone will have chemotherapy. Some people will also have lung sparing surgery and some people won’t have this surgery.
The aims of this trial are to:
- find out whether chemotherapy alone or chemotherapy and surgery is better at treating mesothelioma
- learn more about the side effects of these 2 treatment groups
- look at the costs associated with these 2 treatment groups
Who can enter
You may be able to join this study if all of the following apply.
- You have pleural mesothelioma affecting only one side of your chest and this has been confirmed by CT scan
- You have one of the following types of mesothelioma - epithelioid, sarcomatoid or biphasic mesothelioma
- Your surgeon has recommended surgery and you are fit and well enough to have an operation
- You are well enough to carry out all your normal activities, apart from heavy physical work (performance status of 0 or 1)
- You are aged 16 years or older
You cannot join this study if any of these apply. You
- Have difficulty breathing (you have some tests to assess your breathing)
- Have severe heart failure
- Have end stage kidney failure and you need dialysis to treat this
- Have liver failure
- Have any other serious medical condition that the trial team think could affect you taking part
- Are taking part in another clinical trial (you may be able to take part in some trials at the same time, the trial can explain this more to you)
- Are in prison
This is a phase 3 trial. The researchers need 328 people to join.
First of all, everyone taking part has chemotherapy for mesothelioma. Your doctor will decide which drugs you have. You have these drugs through a drip into a vein once every 3 weeks. Each 3 week period is called a cycle of treatment and you have 2 cycles. You would have this chemotherapy as part of your standard treatment, whether you take part in this trial or not.
Your doctor will then decide if it is still possible for you to have surgery. If your doctor doesn’t think it is possible to remove your cancer with surgery, they will discuss whether any other treatment is suitable for you. You will no longer be part of this trial.
If you are able to have surgery, you take part in the next stage of the trial which is randomised. The people taking part are put into 1 of 2 treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in.
People in one group have surgery and people in the other group do not have surgery.
If you don’t have surgery, you will continue to have up to 4 further cycles of chemotherapy. This is standard treatment.
If you have surgery, you have a
When you wake up you will have drainage tubes from your chest into a bottle to stop fluid collecting in your chest. You also have a drip into a vein in your arm to give you fluids until you are able to drink again. We have more information about what to expect in the first few days after surgery for mesothelioma.
After recovering from surgery you have up to 4 more cycles of chemotherapy. You would have this chemotherapy as part of your standard treatment, whether you take part in this trial or not.
Questionnaire and interview
The trial team will ask everyone who takes part to fill out a questionnaire before you start chemotherapy. If you then join the randomised part of the trial you fill out this questionnaire on 5 different occasions over the course of 2 years. The questionnaire will ask about side effects and how you’ve been feeling. This is called a quality of life study.
If you are suitable to take part in the randomised part of the trial, the researchers may also ask you to take part in an interview. You don’t have to take part in this interview if you don’t want to, you can still take part in the main trial.
A researcher will ask you:
- about your experiences of taking part in this trial
- why you agreed to take part
- how people can be best supported
This is called the Information sub study. You might also be asked for your permission for any discussions around joining the trial to be audio-recorded.
You see the doctors and have some tests before you start treatment. The tests include:
- a physical examination
- blood tests
- tests to check that your lungs are working well (
lung function tests)
- a CT scan so that your doctor can decide whether it is possible to remove your cancer with surgery
You then go to hospital twice over the course of 6 weeks to have your chemotherapy. You have another CT scan to check you are still suitable for surgery.
If you have surgery, you have more blood tests and various other tests in preparation for your surgery (the trial team will give you more detail about this). You stay in hospital for about 10 to 14 days. About 3-6 weeks after your surgery you go to hospital again for a check-up. All patients having surgery would have this check up as part of standard care, whether they take part in this trial or not.
Everyone in the trial will go to hospital about every 3 weeks to have 4 more cycles of chemotherapy. When you finish treatment, you go to hospital to see a doctor who will ask about your general health and to have blood tests. These appointments will take place:
- after 6 weeks
- then every 3 months for the rest of the first year
- every 6 months for the second year
- every year for the next 3 years
The risks or side effects of a pleurectomy decortication or an extended pleurectomy decortication include:
- blood clots in the leg or the lung
Your surgeon will talk to you about the risk of other, rarer side effects.
You have pain relief immediately after your operation and while you are recovering. The doctors and nurses will monitor you closely for any side effects so that treatment can be given promptly if you need it.
The side effects of chemotherapy for mesothelioma include:
How to join a clinical trial
Mr Eric Lim
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Papworth Hospital NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust
This is a Cancer Research UK trial number CRUK/12/030.